Conference Coverage

Positive headway reported for progressive multiple sclerosis

Publish date: February 25, 2016

 

EXPERT ANALYSIS FROM ACTRIMS FORUM 2016

References

Dr. Lublin reported receiving research support and/or serving as a consultant for many companies marketing MS drugs, including Biogen, Genentech, and Novartis.

Pages

Recommended Reading

Study suggests radiologically isolated disease is part of MS spectrum
MDedge Internal Medicine
New case of MS possibly related to tocilizumab
MDedge Internal Medicine
Study confirms value of watching JCV serology during natalizumab treatment
MDedge Internal Medicine
Three lesions needed for MRI diagnosis of MS
MDedge Internal Medicine
Gender identity disorders in males associated with MS
MDedge Internal Medicine
VIDEO: ACTRIMS Forum focuses on progressive MS
MDedge Internal Medicine
ACTRIMS: Treadmill exercise transiently benefits cognition in MS patients
MDedge Internal Medicine
ACTRIMS: Ovarian decline linked to MS progression in women
MDedge Internal Medicine
Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions
MDedge Internal Medicine
VIDEO: MS stem cell therapy research progresses, including oligodendrocyte progenitor trial
MDedge Internal Medicine

Related Articles